BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2812651)

  • 21. [Preterm premature rupture of membranes in the 19th week of pregnancy. A clinical case].
    Bastianelli C; Valente A; Lucantoni V; Dionisi B; Cerenzia G
    Minerva Ginecol; 1999 Apr; 51(4):139-43. PubMed ID: 10379151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are amniotic fluid C-reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery?
    Tarim E; Bağiş T; Kiliçdağ EB; Sezgin N; Yanik F
    J Perinat Med; 2005; 33(6):524-9. PubMed ID: 16318616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of premature rupture of membranes before 25 weeks.
    Muris C; Girard B; Creveuil C; Durin L; Herlicoviez M; Dreyfus M
    Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):163-8. PubMed ID: 16846673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy outcome following genetic amniocentesis at 11-14 versus 16-19 weeks' gestation.
    Brumfield CG; Lin S; Conner W; Cosper P; Davis RO; Owen J
    Obstet Gynecol; 1996 Jul; 88(1):114-8. PubMed ID: 8684742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic amniocentesis complications: is the incidence overrated?
    Nassar AH; Martin D; González-Quintero VH; Gómez-Marín O; Salman F; Gutierrez A; O'Sullivan MJ
    Gynecol Obstet Invest; 2004; 58(2):100-4. PubMed ID: 15178899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early amniocentesis at 10-12 weeks' gestation.
    Diaz Vega M; De La Cueva P; Leal C; Aisa F
    Prenat Diagn; 1996 Apr; 16(4):307-12. PubMed ID: 8734803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimally invasive endoscopy in the treatment of preterm premature rupture of membranes by application of fibrin sealant.
    Young BK; Roqué H; Abdelhak YE; Poiolek D; Demopulos R; Lockwood CJ
    J Perinat Med; 2000; 28(4):326-30. PubMed ID: 11031705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of amniocentesis in preterm gestation with ruptured membranes.
    Cotton DB; Hill LM; Strassner HT; Platt LD; Ledger WJ
    Obstet Gynecol; 1984 Jan; 63(1):38-43. PubMed ID: 6691016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of twin-twin transfusion syndrome in pregnancies with iatrogenic detachment of membranes following therapeutic amniocentesis and the role of interim amniopatch.
    Quintero RA; Kontopoulos EV; Chmait R; Bornick PW; Allen M
    Ultrasound Obstet Gynecol; 2005 Nov; 26(6):628-33. PubMed ID: 16217744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of pregnancies after non-amniocentesis-induced premature rupture of membranes at 14 to 23 weeks' gestation.
    Scholz HS; Arikan MG; Benedicic C; Petru E; Haas J; Weiss PA
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):50-3. PubMed ID: 12407936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preterm prelabour rupture of the membranes before 28 weeks: better than feared outcome of expectant management in Africa.
    Stewart CJ; Tregoning SK; Moller G; Wainwright H
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):186-92. PubMed ID: 16229934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications of amniocentesis.
    Brinsmead MW
    Med J Aust; 1976 Mar; 1(12):379-85. PubMed ID: 1272119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-operator comparison of early and mid-second-trimester amniocentesis.
    Assel BG; Lewis SM; Dickerman LH; Park VM; Jassani MN
    Obstet Gynecol; 1992 Jun; 79(6):940-4. PubMed ID: 1579318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of premature rupture of membranes before 26 weeks' gestation.
    Mercer BM
    Obstet Gynecol Clin North Am; 1992 Jun; 19(2):339-51. PubMed ID: 1630742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of amniotic fluid bacterial colonization sampled by amniocentesis in cases with premature rupture of membranes. Prospective multicenter study].
    Berardi JC; Colau JC; Engelmann P; Botto JN; Vige P; Robichez B
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(1):69-73. PubMed ID: 7730571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
    Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
    Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic prophylaxis before second-trimester genetic amniocentesis (APGA): a single-centre open randomised controlled trial.
    Giorlandino C; Cignini P; Cini M; Brizzi C; Carcioppolo O; Milite V; Coco C; Gentili P; Mangiafico L; Mesoraca A; Bizzoco D; Gabrielli I; Mobili L
    Prenat Diagn; 2009 Jun; 29(6):606-12. PubMed ID: 19294678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of brown and/or green amniotic fluid at the time of second trimester genetic amniocentesis.
    Hankins GD; Rowe J; Quirk JG; Trubey R; Strickland DM
    Obstet Gynecol; 1984 Sep; 64(3):353-8. PubMed ID: 6205335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal pulmonary hypoplasia and perinatal mortality in patients with midtrimester rupture of amniotic membranes--a critical analysis.
    Winn HN; Chen M; Amon E; Leet TL; Shumway JB; Mostello D
    Am J Obstet Gynecol; 2000 Jun; 182(6):1638-44. PubMed ID: 10871491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rh sensitization after genetic amniocentesis.
    Hill LM; Platt LD; Kellogg B
    Obstet Gynecol; 1980 Oct; 56(4):459-61. PubMed ID: 6775257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.